Copeptin is increased in resistant hypertension-Reference-Cited by-同舟云学术

Copeptin is increased in resistant hypertension

Published:2016-12 Issue:12 Volume:34 Page:2458-2464
ISSN:0263-6352
Container-title:Journal of Hypertension
language:en
Short-container-title:

Author:

Mendes Margarida,Dubourg Julie,Blanchard Anne,Bergerot Damien,Courand Pierre-Yves,Forni Valentina,Frank Michael,Bobrie Guillaume,Menard Joel,Azizi Michel

Publisher

Ovid Technologies (Wolters Kluwer Health)

Subject

Cardiology and Cardiovascular Medicine,Physiology,Internal Medicine

Reference26 articles.

1. Resistant hypertension: diagnosis, evaluation, and treatment: a scientific statement from the American Heart Association Professional Education Committee of the Council for High Blood Pressure Research;Calhoun;Circulation,2008

2. Resistant hypertension;Fagard;Heart,2012

3. Apparent and true resistant hypertension: definition, prevalence and outcomes;Judd;J Hum Hypertens,2014

4. High prevalence of cardiac and extracardiac target organ damage in refractory hypertension;Cuspidi;J Hypertens,2001

5. A selective endothelin-receptor antagonist to reduce blood pressure in patients with treatment-resistant hypertension: a randomised, double-blind, placebo-controlled trial;Weber;Lancet,2009

Cited by 16 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. The Global Burden of Resistant Hypertension and Potential Treatment Options;European Cardiology Review;2024-06-19

2. Resistant hypertension: Diagnosis, evaluation, and treatment practical approach;European Journal of Internal Medicine;2024-05

3. Resistant Hypertension;Hypertension;2024

4. 2023 ESH Guidelines for the management of arterial hypertension The Task Force for the management of arterial hypertension of the European Society of Hypertension;Journal of Hypertension;2023-09-26

5. Serum copeptin as a biomarker of hypertension in children with obesity;Pediatrics International;2022-01